In CKD patients, the accumulation of uremic toxins and chronic immune activation drive the overproduction of pro-inflammatory cytokines, including C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-1β (IL-1β) (Coyne et al., 2017; David et al., 2016). Here, IL6 is linked to chronic kidney disease.